Walleye Trading LLC Bristol Myers Squibb CO Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

A detailed history of Walleye Trading LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Walleye Trading LLC holds 952,903 shares of BMY stock, worth $55.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

952,903

Previous 97,335 878.99%

Holding current value

$55.2 Million

Previous $4.04 Million 1119.99%

% of portfolio

0.11%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $33.9 Million - $44.3 Million	855,568 Added 878.99%	952,903 $49.3 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $998,119 - $1.31 Million	-24,798 Reduced 20.3%	97,335 $4.04 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $3.48 Million - $3.95 Million	-72,531 Reduced 37.26%	122,133 $6.62 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $5.78 Million - $6.9 Million	-119,191 Reduced 37.98%	194,664 $9.99 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $14.6 Million - $16.3 Million	252,336 Added 410.18%	313,855 $18.2 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $3.92 Million - $4.35 Million	61,519 New	61,519 $3.93 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $9.09 Million - $10.8 Million	132,734 Added 132.35%	233,024 $16.8 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,266 - $1.34 Million	-17,433 Reduced 14.81%	100,290 $7.13 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $404,493 - $445,488	-5,570 Reduced 4.52%	117,723 $9.07 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $4.04 Million - $4.71 Million	75,409 Added 157.48%	123,293 $7.69 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $2.11 Million - $2.47 Million	35,584 Added 289.3%	47,884 $2.83 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $14.5 Million - $15.8 Million	-233,630 Reduced 95.0%	12,300 $822,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $10.4 Million - $11.8 Million	180,266 Added 274.53%	245,930 $15.3 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $5.72 Million - $6.34 Million	-99,614 Reduced 60.27%	65,664 $3.96 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $16.9 Million - $19.8 Million	-308,799 Reduced 65.14%	165,278 $9.72 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $13.5 Million - $19.6 Million	291,092 Added 159.08%	474,077 $26.4 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $8.58 Million - $11.2 Million	174,365 Added 2022.8%	182,985 $11.7 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $143,013 - $185,453	-2,933 Reduced 25.39%	8,620 $448,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $1.2 Million - $1.5 Million	-23,847 Reduced 67.36%	11,553 $639,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $5.77 Million - $6.65 Million	-96,376 Reduced 73.14%	35,400 $2.24 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $2.54 Million - $2.77 Million	-42,413 Reduced 24.35%	131,776 $8.08 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $4.8 Million - $5.54 Million	86,925 Added 99.61%	174,189 $11.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	87,264	87,264 $4.86 Million

Others Institutions Holding BMY

# of Institutions

2,532

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account

Walleye Trading LLC Bristol Myers Squibb CO Transaction History